Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The main purpose is to learn if adding bevacizumab to standard chemotherapy and trastuzumab to treat HER2-positive breast cancer will affect heart function. This study will evaluate: - How bevacizumab, given with chemotherapy, and then bevacizumab given with trastuzumab after surgery, will affect breast tumors - Side effects from adding bevacizumab to chemotherapy and trastuzumab - Whether adding bevacizumab to chemotherapy and trastuzumab for breast cancer will affect the heart - If receiving bevacizumab will have any effect on how patients recover from surgery
Critère d'inclusion
- Breast Cancer